Clinical Trials Logo

Hallux Valgus and Bunion clinical trials

View clinical trials related to Hallux Valgus and Bunion.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06243471 Recruiting - Clinical trials for Hallux Valgus and Bunion

Hallux Abductus Valgus and Extensor Hallux Longus; Treatment by MIS Surgery

HAV-EHL-MIS
Start date: February 1, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this clinical trial is to investigate the relationship between Hallux Abductus Valgus (HAV) and the hyperextension of the Extensor Hallucis Longus (EHL) tendon. The study aims to understand the efficacy of MIS surgery in treating foot deformities like HAV and to evaluate the impact of EHL tendon hyperextension on this condition. The main questions this study aims to answer are: - How does the hyperextension of the EHL tendon correlate with the presence and severity of HAV? - What is the effectiveness of MIS surgery in correcting HAV deformities and addressing issues related to EHL tendon hyperextension? Participants in this study will undergo pre-surgical evaluation to assess the severity of HAV and measure the extent of EHL tendon hyperextension using pressure platform analysis and other relevant clinical measures. During the MIS surgery, participants will receive treatment targeted at correcting HAV, possibly involving partial tenotomy. If there is a comparison group: Researchers will compare individuals who undergo MIS surgery for HAV correction with a control group not receiving this intervention. The comparison aims to assess the effects of MIS surgery on both HAV correction and the relationship between EHL tendon hyperextension and the deformity. This study endeavors to shed light on the relationship between HAV and EHL tendon hyperextension, the effectiveness of MIS surgery in addressing these issues, and potentially pave the way for improved surgical techniques in treating foot pathologies.

NCT ID: NCT04149626 Recruiting - Sedation Clinical Trials

Dexmedetomidine Sedation in Orthopedic Surgery

Start date: January 29, 2020
Phase: Phase 2
Study type: Interventional

60 patients ASA I-III, undergoing orthopedic surgery will be randomly assigned into one of three groups, namely group A (n=20), where dexmedetomidine will be used for sedation (initial bolus dose followed by continuous infusion), group B (n=20) where midazolam will be used for sedation (initial bolus dose followed by continuous infusion) and group C (n=20), where remifentanil will be used for sedation (initial bolus dose followed by continuous infusion). All patients will receive spinal anesthesia. Duration of postoperative analgesia, total dose of patient controlled IV morphine, sedation scores, nausea and vomiting, time of ambulation, sleep quality and patient satisfaction will be recorded for the first postoperative day. Additionally chronic pain on the site of surgery will be recorded in 3 and 6 months postoperatively.